Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126037281 | 12603728 | 1 | I | 201504 | 20150626 | 20160728 | 20160728 | PER | US-MYLANLABS-2015M1021960 | MYLAN | 61.92 | YR | M | Y | 126.98000 | KG | 20160728 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126037281 | 12603728 | 1 | PS | Levothyroxine Sodium Tablets, USP | LEVOTHYROXINE SODIUM | 1 | Oral | 25 ?G, QD | Y | N | 76187 | 25 | UG | TABLET | QD | ||||
| 126037281 | 12603728 | 2 | C | ASPIRIN /00002701/ | ASPIRIN | 1 | Oral | 81 MG, QD | N | 0 | 81 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126037281 | 12603728 | 1 | Hypothyroidism |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126037281 | 12603728 | Dizziness | |
| 126037281 | 12603728 | Flushing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126037281 | 12603728 | 1 | 201504 | 201504 | 0 |